• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/10/21 10:39:37 AM ET
    $BRKS
    Industrial Machinery/Components
    Technology
    Get the next $BRKS alert in real time by email
    SC 13G/A 1 tv0426-brooksautomationinc.htm SCHEDULE 13G/A brooksautomationinc

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 12)*

    Name of issuer:  Brooks Automation Inc.

    Title of Class of Securities:  Common Stock

    CUSIP Number:  114340102

    Date of Event Which Requires Filing of this Statement: December 31, 2020

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  114340102

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    167,808

    7.  SOLE DISPOSITIVE POWER

    7,824,378

    8.  SHARED DISPOSITIVE POWER

    227,691

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    8,052,069

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    10.85%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Brooks Automation Inc.

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    15 Elizabeth Drive
    Chelmsford, MA 01824

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    114340102

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

    8,052,069

      (b) Percent of Class:

    10.85%

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  0

    (ii)  shared power to vote or direct to vote:  167,808

    (iii)  sole power to dispose of or to direct the disposition of:  7,824,378

    (iv)  shared power to dispose or to direct the disposition of:  227,691

    Comments:

     

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    Not applicable

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    See Attached Appendix A

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 8, 2021

    By /s/ Christine M. Buchanan
    Name: Christine M. Buchanan
    Title:  Principal

     

     

    Appendix A

    Subsidiary:

    Vanguard Asset Management, Limited

    Vanguard Fiduciary Trust Company

    Vanguard Global Advisors, LLC

    Vanguard Group (Ireland) Limited

    Vanguard Investments Australia Ltd

    Vanguard Investments Canada Inc.

    Vanguard Investments Hong Kong Limited

    Vanguard Investments UK, Limited

    *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G

     

    Get the next $BRKS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BRKS

    DatePrice TargetRatingAnalyst
    11/17/2021$139.00 → $155.00Buy
    Needham
    11/17/2021$146.00 → $132.00Overweight
    Keybanc
    11/11/2021$100.00 → $120.00Neutral
    Citigroup
    11/10/2021$121.00 → $139.00Buy
    Needham
    9/7/2021$115.00 → $146.00Overweight
    Keybanc
    8/6/2021$130.00 → $114.00Buy
    Needham
    More analyst ratings

    $BRKS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast

      CHELMSFORD, Mass., Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, November 14, 2022 at 4:30 p.m. Eastern Time.  To participate in the conference call, please dial 800-936-4761 for domestic callers and +1-212-231-2922 for international callers. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events.  A replay will be available beginning at 8:3

      11/7/22 4:38:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta Announces Completion of B Medical Systems Acquisition

      CHELMSFORD, Mass., Oct. 3, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has closed its previously announced acquisition of B Medical Systems S.á r.l and its subsidiaries ("B Medical"), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments to more than 150 countries worldwide. This acquisition complements Azenta's cold chain capabilities, adding differentiated solutions for reliable and traceable transport of temperature-sensitive specimens. B Medical, headquartered in Hosingen, Luxembourg, is one of the leading vaccine cold chain providers serving primarily fast-growing emerging markets, w

      10/3/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta to Participate in the Baird 2022 Global Healthcare Conference

      CHELMSFORD, Mass., Sept. 6, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that Company management will participate in the Baird 2022 Global Healthcare Conference in New York City, on Wednesday, September 14, 2022, which includes a presentation beginning at 9:40 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event. About Azenta Life Sciences Azenta, Inc. (NASDAQ:AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain

      9/6/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Leadership Updates

    Live Leadership Updates

    See more
    • Azenta Life Sciences Names Matthew McManus Chief Operating Officer

      CHELMSFORD, Mass., Jan. 6, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th.  In this newly created role, Dr. McManus will oversee Life Sciences Products, Services, and all commercial operations of the business and will report directly to the CEO. "We are excited to have Matt join the Company as our COO," said Steve Schwartz, President and CEO of Azenta. "Matt brings decades of expertise in life sciences. His depth of knowledge and valuable perspective will enhance our leadership position in the markets we serve." Dr. McManus joins Azenta with over 25 years of experience in the life s

      1/6/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham reiterated coverage on Brooks Automation with a new price target

      Needham reiterated coverage of Brooks Automation with a rating of Buy and set a new price target of $155.00 from $139.00 previously

      11/17/21 6:08:56 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • Keybanc reiterated coverage on Brooks Automation with a new price target

      Keybanc reiterated coverage of Brooks Automation with a rating of Overweight and set a new price target of $132.00 from $146.00 previously

      11/17/21 4:42:32 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • Citigroup reiterated coverage on Brooks Automation with a new price target

      Citigroup reiterated coverage of Brooks Automation with a rating of Neutral and set a new price target of $120.00 from $100.00 previously

      11/11/21 10:07:00 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed

      SC 13G - Brooks Automation, Inc. (0000933974) (Subject)

      2/11/21 3:13:09 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form SC 13G/A filed

      SC 13G/A - Brooks Automation, Inc. (0000933974) (Subject)

      2/10/21 10:39:37 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Jarzynka David sold $1,228,883 worth of shares (10,216 units at $120.29), decreasing direct ownership by 18% to 46,315 units

      4 - Brooks Automation, Inc. (0000933974) (Issuer)

      11/22/21 4:16:54 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form 4: Joseph Jason sold $1,036,933 worth of shares (8,694 units at $119.27), decreasing direct ownership by 9% to 89,850 units to cover withholding tax

      4 - Brooks Automation, Inc. (0000933974) (Issuer)

      11/19/21 4:16:49 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form 4: Vacha Robin sold $1,831,384 worth of shares (15,368 units at $119.17), decreasing direct ownership by 40% to 22,932 units (tax withholding)

      4 - Brooks Automation, Inc. (0000933974) (Issuer)

      11/19/21 4:15:33 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    SEC Filings

    See more
    • Brooks Automation, Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

      8-K - Azenta, Inc. (0000933974) (Filer)

      12/1/21 8:15:39 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form 10-K filed by Brooks Automation, Inc.

      10-K - Brooks Automation, Inc. (0000933974) (Filer)

      11/24/21 9:17:52 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • Brooks Automation, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Brooks Automation, Inc. (0000933974) (Filer)

      11/10/21 4:35:48 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Financials

    Live finance-specific insights

    See more
    • Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast

      CHELMSFORD, Mass., Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, November 14, 2022 at 4:30 p.m. Eastern Time.  To participate in the conference call, please dial 800-936-4761 for domestic callers and +1-212-231-2922 for international callers. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events.  A replay will be available beginning at 8:3

      11/7/22 4:38:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 2022

      CHELMSFORD, Mass., Aug. 9, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the third quarter ended June 30, 2022. Quarter Ended Dollars in millions, except per share data June 30,  March 31,  June 30,  Change 2022 2022 2021 Prior Qtr. Prior Yr. Revenue from Continuing Operations $ 133 $ 146 $ 129 (9) % 3 % Life Sciences Products $ 47 $ 54 $ 49 (12) % (3) % Life Sciences Services $ 85 $ 92 $ 80 (7) % 6 % Diluted EPS Continuing Operations $ (0.09) $ (0.02) $ (0.02) nm nm Diluted EPS Total $ (0.13) $ 28.28 $ 0.53 nm nm Non-GAAP Diluted EPS Continuing Operations $ 0.12 $ 0.12 $ 0.10 0 % 14 % Adjusted EBITDA Continuing Operations $ 14 $ 19 $ 19 (29) % (26) % M

      8/9/22 4:20:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta Announces Agreement to Acquire B Medical Systems

      Enhances Azenta's Leadership Position in Cold Chain Solutions and End-to-End Sample Management CHELMSFORD, Mass., Aug. 8, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has entered into a definitive agreement to acquire B Medical Systems S.á r.l and its subsidiaries ("B Medical"), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe. The cash purchase price to be paid at closing will be approximately €410 million. Additional cash consideration, up to €50 million, may be paid upon achievement of certain future performance milestones. The transaction is expected to close in O

      8/8/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology